Found: 12
Select item for more details and to access through your institution.
Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models.
- Published in:
- Cellular Oncology (2211-3428), 2022, v. 45, n. 4, p. 639, doi. 10.1007/s13402-022-00689-2
- By:
- Publication type:
- Article
Novel protein kinase inhibitor TT-00420 inhibits gallbladder cancer by inhibiting JNK/JUN-mediated signaling pathway.
- Published in:
- Cellular Oncology (2211-3428), 2022, v. 45, n. 4, p. 689, doi. 10.1007/s13402-022-00692-7
- By:
- Publication type:
- Article
VHL and DNA damage repair pathway alterations as potential clinical biomarkers for first-line TKIs in metastatic clear cell renal cell carcinomas.
- Published in:
- Cellular Oncology (2211-3428), 2022, v. 45, n. 4, p. 677, doi. 10.1007/s13402-022-00691-8
- By:
- Publication type:
- Article
AKT inhibition sensitizes EVI1 expressing colon cancer cells to irinotecan therapy by regulating the Akt/mTOR axis.
- Published in:
- Cellular Oncology (2211-3428), 2022, v. 45, n. 4, p. 659, doi. 10.1007/s13402-022-00690-9
- By:
- Publication type:
- Article
Spatiotemporal modulation of SMAD4 by HBx is required for cellular proliferation in hepatitis B-related liver cancer.
- Published in:
- Cellular Oncology (2211-3428), 2022, v. 45, n. 4, p. 573, doi. 10.1007/s13402-022-00683-8
- By:
- Publication type:
- Article
Inhibition of CD146 lessens uveal melanoma progression through reducing angiogenesis and vasculogenic mimicry.
- Published in:
- Cellular Oncology (2211-3428), 2022, v. 45, n. 4, p. 557, doi. 10.1007/s13402-022-00682-9
- By:
- Publication type:
- Article
Glioblastoma, from disease understanding towards optimal cell-based invitro models.
- Published in:
- Cellular Oncology (2211-3428), 2022, v. 45, n. 4, p. 527, doi. 10.1007/s13402-022-00684-7
- By:
- Publication type:
- Article
EV-miRome-wide profiling uncovers miR-320c for detecting metastatic colorectal cancer and monitoring the therapeutic response.
- Published in:
- Cellular Oncology (2211-3428), 2022, v. 45, n. 4, p. 621, doi. 10.1007/s13402-022-00688-3
- By:
- Publication type:
- Article
The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma.
- Published in:
- Cellular Oncology (2211-3428), 2022, v. 45, n. 4, p. 601, doi. 10.1007/s13402-022-00686-5
- By:
- Publication type:
- Article
Genomic copy number alterations as biomarkers for triple negative pregnancy-associated breast cancer.
- Published in:
- Cellular Oncology (2211-3428), 2022, v. 45, n. 4, p. 591, doi. 10.1007/s13402-022-00685-6
- By:
- Publication type:
- Article
Role of ELMO1 in inflammation and cancer—clinical implications.
- Published in:
- Cellular Oncology (2211-3428), 2022, v. 45, n. 4, p. 505, doi. 10.1007/s13402-022-00680-x
- By:
- Publication type:
- Article
Application of circulating tumour cells to predict response to treatment in head and neck cancer.
- Published in:
- Cellular Oncology (2211-3428), 2022, v. 45, n. 4, p. 543, doi. 10.1007/s13402-022-00681-w
- By:
- Publication type:
- Article